I continue to believe the market is significantly under estimating the impact of this blockbuster drug and its future prospects on the company. The only issue here is in order to increase the distribution network, the company may have to do a large secondary which could put a lid on the stock temporarily. But if that happens, I expect the market to easily absorb the dilution given the bright future. Regardless, I am buying the following calendar spread:- Buy to open Aug $60 calls
- Sell to open May $60 calls
I just filled the order for $2.90 net debit.
Good luck!
